Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates

Abstract

Background:

Dexamethasone or indomethacin predisposes very low birth weight (VLBW) neonates to spontaneous intestinal perforation (SIP). However, no study has specifically investigated the role of the concurrent use of indomethacin and dexamethasone in SIP.

Objective:

To test whether the concurrent use of indomethacin and dexamethasone increases the risk of SIP.

Methods:

In this single center, retrospective, 2:1 matched, case–control study, the odds of SIP were assessed using univariate and multivariate logistic regression analysis in 14-day old VLBW infants.

Results:

Sixteen VLBW infants with SIP were matched to 32 controls by birth weight. After adjusting for clinically relevant variables, patients who received 3 doses of indomethacin for ductal closure or intraventricular hemorrhage prophylaxis and 3 doses of low-dose dexamethasone (0.3 mg/kg cumulative dose over 3 days) for refractory hypotension during the first postnatal week, were 9.6 times more likely to develop SIP [95% CI 1.22, 75.71].

Conclusions:

The combined use of indomethacin and dexamethasone increases the risk of SIP in VLBW neonates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Pumberger W, Mayr M, Kohlhauser C, Weninger M . Spontaneous localized intestinal perforation in very-low-birth-weight infants: a distinct clinical entity different from necrotizing enterocolitis. J Am Coll Surg 2002; 195: 796–803.

    Article  Google Scholar 

  2. Holland AJ, Shun A, Martin HC, Cooke-Yarborough C, Holland J . Small bowel perforation in the premature neonate: congenital or acquired? Pediatr Surg Intl 2003; 19: 489–494.

    Article  CAS  Google Scholar 

  3. Attridge JT, Herman AC, Gurka MJ, Griffin MP, McGahren ED, Gordon PV . Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations. J Perinatol 2006; 26: 49–54.

    Article  CAS  Google Scholar 

  4. Mintz AC, Applebaum H . Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg 1993; 28: 857–860.

    Article  CAS  Google Scholar 

  5. Novack CM, Waffarn F, Sills JH, Pousti TJ, Warden MJ, Cunningham MD . Focal intestinal perforation in the extremely-low-birth-weight infant. J Perinatol 1994; 14: 450–453.

    CAS  PubMed  Google Scholar 

  6. Komuro H, Urita Y, Hori T, Hirai M, Kudou S, Gotoh C et al. Perforation of the colon in neonates. J Pediatr Surg 2005; 40: 1916–1919.

    Article  Google Scholar 

  7. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz KD . Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr 1988; 113: 364–367.

    Article  CAS  Google Scholar 

  8. Shorter NA, Liu JY, Mooney DP, Harmon BJ . Indomethacin-associated bowel perforations: a study of possible factors. J Pediatr Surg 1999; 34: 442–444.

    Article  CAS  Google Scholar 

  9. DeLaet MH, Dassonville M, Johansson A, Lerminiaux C, Seghers V, VandenEijnden S et al. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone. Eur J Pediatr Surg 2000; 10: 323–327.

    Article  CAS  Google Scholar 

  10. Cass DL, Brandt ML, Patel DL, Nuchtern JG, Minifee PK, Wesson DE . Peritoneal drainage as definitive treatment for neonates with isolated intestinal perforation. J Pediatr Surg 2000; 35: 1531–1536.

    Article  CAS  Google Scholar 

  11. Okuyama H, Kubota A, Oue T, Kuroda S, Ikegami R, Kamiyama M . A comparison of the clinical presentation and outcome of focal intestinal perforation and necrotizing enterocolitis in very-low-birth-weight neonates. Pediatr Surg Int 2002; 18: 704–706.

    PubMed  Google Scholar 

  12. Zamir O, Goldberg M, Udassin R, Peleg O, Nissan S, Eyal F . Idiopathic gastrointestinal perforation in the neonate. J Pediatr Surg 1988; 23: 335–337.

    Article  CAS  Google Scholar 

  13. Meyer CL, Payne NR, Roback SA . Spontaneous isolated intestinal perforations in neonates with birth weight <1000 g not associated with necrotizing enterocolitis. J Pediatr Surg 1991; 26: 714–717.

    Article  CAS  Google Scholar 

  14. Resch B, Mayr J, Kuttnig-Haim M, Reitere F, Ritschl E, Muller W . Spontaneous gastrointestinal perforation in very-low-birth-weight infants – a rare complication in a neonatal intensive care unit. Pediatr Surg Int 1998; 13: 165–167.

    Article  CAS  Google Scholar 

  15. Raghuveer G, Speidel B, Marlow N, Porter H . Focal intestinal perforation in preterm infants is an emerging disease. Acta Paediatr 1996; 85: 237–239.

    Article  CAS  Google Scholar 

  16. Attridge JT, Clark R, Walker MW, Gordon PV . New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2005 [E-Pub Dec, 1–7].

  17. Adderson EE, Pappin A, Pavia AT . Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J Pediatr Surg 1998; 33: 1463–1467.

    Article  CAS  Google Scholar 

  18. Ng PC, Fok TF, So KW, Wong W, Yip PKF, Liu K . Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia. Pediatr Surg Int 1997; 12: 211–212.

    Article  Google Scholar 

  19. Gordon P, Rutledge J, Sawin R, Thomas S, Woodrum D . Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol 1999; 19: 573–577.

    Article  CAS  Google Scholar 

  20. Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999; 104: 91–99.

    Article  CAS  Google Scholar 

  21. Gordon PV, Marshall DD, Stiles AD, Price WA . The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: from the baby's bowel to the researcher's bench. Mol Genet Metab 2001; 72: 91–103.

    Article  CAS  Google Scholar 

  22. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344: 95–101.

    Article  CAS  Google Scholar 

  23. Gordon PV, Young ML, Marshall DD . Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J Perinatol 2001; 21: 156–160.

    Article  CAS  Google Scholar 

  24. Halliday HL, Ehrenkranz RA, Doyle LW . Early postnatal (<96 h) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; 1: CD001146.

    Google Scholar 

  25. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114: 1649–1657.

    Article  Google Scholar 

  26. Schmidt B, David P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.

    Article  CAS  Google Scholar 

  27. Malviya M, Ohlsson A, Shah S . Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; 1: CD003951.

    Google Scholar 

  28. Alpan G, Eyal F, Vinograd I, Udassin R, Amir G, Mogle P et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 1985; 106: 277–281.

    Article  CAS  Google Scholar 

  29. Giacoia GP, Azubuike K, Taylor JR . Indomethacin and recurrent ileal perforations in a preterm infant. J Perinatol 1993; 13: 297–299.

    CAS  PubMed  Google Scholar 

  30. Buchheit JQ, Stewart DL . Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates. Pediatrics 1994; 93: 32–36.

    CAS  PubMed  Google Scholar 

  31. Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD . Patent ductus arteriosus in micropreemies and full-term infants: The relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 2003; 38: 492–496.

    Article  Google Scholar 

  32. Knowles RG, Salter M, Brooks S, Moncada S . Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 43–47.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Paquette.

Additional information

This study was presented at the Pediatric Academic Societies' Annual Meeting in Washington, DC, May 14–17, 2005.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paquette, L., Friedlich, P., Ramanathan, R. et al. Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates. J Perinatol 26, 486–492 (2006). https://doi.org/10.1038/sj.jp.7211548

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211548

Keywords

This article is cited by

Search

Quick links